Lactiplantibacillus plantarum/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases alanine aminotransferase
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Hepatocellular injury markers (AST and ALT) remained within normal limits, although ALT showed a small but statistically significant decrease in the probiotic group compared to a slight increase in the placebo group (Δ0–6: −0.32 vs. 5.03 U/L, p = 0.035).”
Quoted verbatim from Safety of Lactiplantibacillus plantarum K014 in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial.. - Study
- RCT
- Duration
- 6 months
- Dose
- one sachet daily, at least 1 x 10^9 CFU L. plantarum K014 with 2 g maltodextrin, for 24 weeks
- Population
- Healthy Malaysian adults aged 18 and over; change from baseline to month 6; maltodextrin placebo in the comparator arm
Safety of Lactiplantibacillus plantarum K014 in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial.2026PMID:42124006Permalink
Keep reading
- Everything the graph holds on Lactiplantibacillus plantarum
- Every compound studied against Alanine aminotransferase
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45XA523H6H14XE4X3Q8F4YA